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ABSTRACT 
Glioblastoma multiforme (GBM) is the most common and malignant primary brain tumour 
in adults. Despite current treatment options, including surgery followed by radiation and 
chemotherapy with temozolomide (TMZ) and cisplatin, the median survival rate remains 
below 16 months. Epidemiological studies have shown a positive correlation between 
consumption of fruits and vegetables in the reduced risk and prevention of cancers, 
resulting in improved mortality rates. This is due to various fruits encompassing differing 
antioxidant abilities, which are derived from their phytochemical components. Research has 
emphasised the importance of antioxidants and their ability to neutralise reactive oxygen 
species (ROS) which cause oxidative damage to lipids, proteins and nucleic acids. This 
study examined the presence of polyphenolic compounds within five fruits: cranberry, 
strawberry, goji berry, maqui berry and acai berry, and their effect on cell viability. 
Through High Performance Liquid Chromatography, it was possible to identify the 
potential of all fruits to contain antioxidants; specifically, gallic acid, punicalagin, cyanidin-
3-glucoside and malvidin. Subsequently, flavonoid and phenolic assays quantified the 
levels of antioxidants present within the fruits whereby, cranberry had the highest total 
flavonoid content (670.93 ±45.30 µg/CE/serving) and strawberry had the highest total 
phenolic content (2835.11± 26.48 µg/GAE/serving). Also, the DPPH· radical scavenging 
assay quantified antioxidant activity of fruits and phytochemical compounds showing 
punicalagin to have the highest antioxidant activity (6522.74 ± 59.30 µM TROLOX 
equivalents). The results presented a significant difference in each assay, between all fruits 
samples (p<0.001). This identified cranberry to contain the highest antioxidant activity 
when compared to the other fruits. This study examined the effect of the fruit extracts and 
antioxidant compounds in comparison to cisplatin and determined effects on cell viability. 
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Cyanidin-3-glucoside and maqui berry significantly reduced the viability of U87-MG cells. 
These results suggest a potential for antioxidants as chemotherapeutic agents in the 
treatment of glioblastoma multiforme.  
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1.1 Brain Tumours 
Cancers are a huge research topic as 292,680 invasive malignant cancer diagnoses were 
registered in 2013, in England (Office for National Statistics, 2015; Cancer Registration 
Statistics, England, 2013). Of these, 133,000 deaths occurred, in England in 2013, from a 
total of 162,000 in the UK (Macmillan Cancer Support). Specifically, little significance is 
given to brain tumours in comparison to other cancers such as breast cancer. Brain tumour 
incidences within the UK range from 2,398 in males and 1,803 in females (Figure 1.1) 
(Office or National Statistics, 2016).  
 
Like other cancer, the cause of brain tumours is unknown. However, several risk factors 
have been established such as age, medical radiation, recurrence from previous cancers and 
other medical conditions such as HIV or AIDS (cancer Research, UK). This report 
emphasises    the challenges that remain in the diagnosis and treatment of brain cancers and 
understands the importance of developing new treatments. 
 
 
 
 
 
 
 
 
16 
 
1.2. Glioblastoma Multiforme  
Glioma can be astrocytic, oligodentritic and ependymal in origin and accounts for 70% of 
brain tumours; of which the most frequent (65%) is glioblastoma (Ohgaki et al., 2005). 
Current classification is based on the widely accepted World Health Organisation (WHO) 
grading system. As shown in Table 1.1, glioma are identified by the type of cell affected: 
divided into astrocytoma, oligodendroglioma, mixed oligoastrocytomas and glioblastoma. 
They are also classified by grade (II-IV), based on abnormal nuclear structure, cellular 
proliferation, microvascular proliferation and necrosis. Tumours can be classified as grade I 
which are usually solid and non-infiltrative (Vigneswaran et al., 2015; Louis et al., 2016). 
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Table 1.1: World Health Organisation examples of classification of gliomas. This is in 
accordance with type, grade, and survival rate alongside a description of the cancer (Louis 
et al., 2016). 
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1.3 Treatment of Glioblastoma Multiforme 
 
 
Despite medical advances in cancer, GBM has limited success. Current treatment consists 
of surgery followed by radiation therapy (RT) in the form of fractionated external beam 
radiotherapy (EBRT) and chemotherapy with temozolomide (TMZ) (Stupp et al., 2005). 
 
Initial treatment begins with surgery to obtain a histological diagnosis and safely remove as 
much tumour as possible. Resection can be problematic due to the invasiveness, increased 
vascularisation or position such as proximity to the motor cortex. In such cases, the tumour 
is partially removed if safe to do so. Full or partial removal of the tumour can be 
advantageous by decreasing symptoms thus reducing the need for additional radiation and 
chemotherapies, reducing side effects resulting in improved quality of life (Watts et al., 
2014). However, risks are associated with surgery as it is difficult to clearly differentiate 
between tumorous and healthy tissue which has potential for error (Watts et al., 2014).  
 
RT is assumed to be effective at delivering a high dose, localised treatment with minimal 
invasion to surrounding tissue. Studies explored the success rate of RT, however Souhami 
et al. (2004) found RT to have no significant difference within the survival rates. Although 
there have been steady advances in treatment to improve survival rates whilst improving 
the quality of life amongst patients (Barani and Larson., 2015). 
 
Medical therapy in the form of alkylating agents such as TMZ have been found 
advantageous due to their rapid and complete absorption upon oral administration and their 
excellent penetration into body tissues including the brain. TMZ is able to select a 
methylation site upon DNA, specifically N7 and O6 on guanine and O3 on adenine resulting 
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in a cascade of events leading to repetitive futility in base pair mismatch repair causing 
chronic strand breaks, triggering an apoptotic response (Stupp et al., 2001). The exploration 
into the combination of TMZ and RT were found to increase cytotoxicity which established 
a success in the relationship and was suggested to be used as a combination therapy (Stupp 
et al., 2001). 
 
Another medical therapy consists of cisplatin or Cis-diamminedichloroplatinum (CDDP), 
considered one of the most potent and widely used drugs for cancer treatment. Cisplatin is a 
metallic- platinum coordination compound with a square planar structure which is 
composed of a doubly charged platinum ion surrounded by four ligands. Within this 
structure, the amine ligands form stronger bonds with the platinum ion and the chloride 
ions forming leaving groups allowing the platinum ion to bond with DNA bases (Dasari 
et.al., 2014). The mode of action of its cytotoxicity is mediated by its interaction with 
DNA, activating several pathways including those with the involvement of ATR, p53, p73 
and MAPK, all which cumulate in activation of apoptosis as summarised in Figure 1.2. 
Although TMZ is the current drug treatment for GBM, cisplatin therapy is used for 
recurrent childhood brain tumours. However, due to cisplatin’s interaction with DNA it is 
known to have cytotoxic effects including nephrotoxicity, hepatotoxicity and cardiotoxicity 
(Yousef et.al.,2009) 
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Figure 1.2: shows the pathways through which cisplatin leads to apoptosis dependent 
upon crosstalk between pathways and the intensity of signal67tnming (Siddik, 2003). 
 
Despite these combinations, as well as advances in each treatment option individually, 
prognosis is still poor. This could be due to the GBM cell resistance to TMZ and cisplatin 
possibly due to the role of a specific microRNA (Clarke et al., 2010). In TMZ, 
methylguanine methyltransferase (MGMT), a DNA repair protein which is able to bind to 
damaged substrate DNA, resulting in a conformational change of the DNA, detaching and 
then allowing the DNA to go through the degradation system. MGMT is able to protect 
cells against carcinogens however, it can also protect cancer cells from chemotherapeutic 
agents such as TMZ (Zhang et al., 2012) (Figure 1.3). As well as investigations into 
intensity modulated radiotherapy and other therapies, there are still few approved treatment 
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alternatives. Recurrence of the disease has been found problematic, where the same 
treatment is administered and fails to show the same success; as well as the difficulty of 
drugs crossing the blood brain barrier (Clarke et al., 2010). 
Figure 1.3: Shows the pathway through which TMZ interacts with MGMT and other 
DNA repair mechanisms leading to cytotoxicity within cells (Liu, 2006).  
 
 
1.4 Reactive Oxygen Species and Antioxidants 
 
 
Reactive oxygen species (ROS) are chemically reactive by-products of oxygen metabolism 
and can be generated in response to xenobiotics, cytokines and bacterial invasion; and 
external exposure such as air pollutants, X-rays and industrial chemicals (Lobo, 2010). 
Under normal cellular conditions, ROS can be obtained through enzymatic and non-
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enzymatic reactions. Where enzymatic reactions are a source of ROS through involvement 
in defence mechanisms such as phagocytosis and redox signalling; non-enzymatic reactions 
form ROS through oxygen and organic compound reactions having similar beneficial 
effects (Lobo, 2010; Halliwell, 2007).  
 
 In high concentrations ROS can have damaging effects upon cellular components 
including DNA, proteins and lipids; contributing to the development of diseases such as 
cancer, atherosclerosis, cardiovascular disease, diabetes mellitus and neurodegenerative 
disease (Gordon 1996; Gey, 1990; Scalbert et al., 2005). Free radicals known to create such 
damage consist of the hydroxyl (·OH), superoxide anion and hydrogen peroxide. For 
example, the reduction of molecular O2 produces superoxide (·O2−) which can be further 
converted to hydrogen peroxide (H2O2) and hydroxyl radical (·OH).  
 
Cell damage can occur due to protein and lipid peroxidation leading to apoptosis. In 
proteins, as a result of oxidative stress, physical and chemical changes can occur causing 
biological consequences including disease and aging. Specifically, oxidative modifications 
of proteins take place at the side chains of amino acids. Cysteine and methionine are 
especially susceptible to oxidation due to the presence of reactive sulphur atoms which is 
rich is electrons and can be removed. ROS can directly attack the backbone of proteins to 
cause conformational changes in the secondary and tertiary structures (Zhang et al., 2013). 
 
Lipid peroxidation takes place due to an antioxidant deficiency (α-tocopherol). The process 
consists of the formation and propagation of lipid radicals, uptake of oxygen, and a 
rearrangement of the double bonds in unsaturated lipids, specifically within 
polyunsaturated fatty acids (PUFA). This causes an increase in radical formation by 
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hydrogen abstraction due to the susceptibility of a weak C-H bond within the methylene 
bridge resulting in the formation of a peroxyl radical (ROO·) and hydroperoxides. This 
leads to a chain reaction, where the ROO· alongside a yield of alcoxyl (RO.) or hydroxyl 
(·OH) radicals is able to start the procedure of forming and propagating lipid radicals again. 
Under high levels of lipid peroxidation, the membranes under attack are overwhelmed by 
oxidative damage such that they are unable to put repair mechanisms in place, inducing 
apoptosis or necrosis. This leads to the eventual destruction of PUFA and therefore lipid 
membranes, with breakdown products including: alcohols, ketones, alkanes, aldehydes and 
ethers (Dianzani et al., 2008; Repetto, 2012; Ayala et al., 2014).  
 
To defend against such damage, oxidative mechanisms are put in place with the aid of 
antioxidants which can prevent radical formation, remove radicals before they can cause 
damage to key components and repair oxidative damage. However, it is imperative for an 
exacting amount of ROS to remain, to carry out necessary processes and so the aim of these 
mechanisms is not to remove all ROS but to maintain the levels to prevent such damage 
from occurring (Ames et al., 1993; Gordon, 1996).  
 
According to Lobo et al., (2010), proposed defence mechanisms consist of the donation of 
an electron from the antioxidant, neutralising the free radical; removal of ROS by 
quenching the chain initiating catalyst; metal ion chelation; co-antioxidants or gene 
expression regulation. These antioxidants can be generated naturally or obtained via the 
diet.  
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Reduction of molecular O2 produces superoxide (·O2−) which can be further converted to 
hydrogen peroxide (H2O2) and hydroxyl radical (·OH). Naturally occurring enzymatic 
antioxidants found within cells, have the ability to convert ROS in to less toxic products. 
The antioxidant superoxide dismutase (SOD) enzyme catalyses the dismutation (alternately 
adding or removing an electron from the superoxide molecules it encounters) of the ·O2− 
radical to produce the less harmful products H2O2 and O2 (Figure 1.3). Alongside SOD, 
another enzymatic antioxidant catalase, prevents the increased production of H2O2, also a 
harmful by product; decomposing it to O2 and H2O.  Other antioxidants include, ascorbic 
acid (vitamin C), α-tocopherol (vitamin E), uric acid and the glutathione (GSH) (all non-
enzymatic) which also target H2O2. 
 
  
Figure 1.4: Equation showing the breakdown of ·O2− (adapted from Gordon, 1996). 
 
1.5 Phytochemicals  
 
 
Phytochemicals are bioactive non-nutrient plant compounds which have particular roles 
within plants such as contributing to reproduction and growth, defence mechanisms against 
pathogens and parasites, as well as colour of the plant (Liu, 2004; Lampe et al., 2007). 
Upon human consumption of these phytochemicals, studies have indicated a potential for 
them to have chemotherapeutic advantages (Ames, 1983; Gey, 1990). Phytochemicals can 
be classified into five categories; phenolics, carotenoids, nitrogen-containing compounds, 
organosulfur compounds and alkaloids, of which carotenoids and phenolics are the most 
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studied and phenolics are the most common and widely distributed (Figure 1.4) (Tsao, 
2010). 
 
 
 
Figure 1.5: Classification of phytochemicals recognising those which have been widely 
researched (Adapted from Liu, 2004) 
 
Carotenoids and phenolics from the same basic chemical structure and are differentiated by 
the addition of functional groups which also differentiate the phytochemicals’ roles within 
plants (Table 1.2). It is their roles within plants that have been identified to aid in 
antioxidant defence mechanisms due to their ability to quench ROS and prevent lipid 
peroxidation (Gordon 1996). 
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1.5.1 Flavonoids 
 
Flavonoids are the most widely studied of the phenolics with over 4000 discovered to date.  
They are typically found in glycosylated or esterified forms, all leading to variation in role, 
and can be further divided into subgroups: flavonols, catechins, flavones, flavanones, 
anthocyanins and isoflavones (Liu, 2004; Manach, 2004). The general structure of 
flavonoids contains a C6-C3-C6 backbone, of which rings A and B are phenolic in nature 
(Table 1.3). Ring C is the part of the structure which further sub-divides the flavonoids 
where variations can occur due to hydroxylation patterns, and positioning of the connection 
between rings B and C, which can result in the flavonoids existing as glycosides (Tsao, 
2010).  
 
Like other phytochemicals, the variants of flavonoids have antioxidant capabilities as they 
are hydroxylated phenolic substances. The sub-divisions of flavonoids are structure 
dependent which in turn arranges their chemical nature through their degree of 
hydroxylation polymerisation and substitutions. The variant consists of the functional 
hydroxyl group which determines the flavonoids antioxidant capability which allows the 
scavenging of free radicals (Kumar et al., 2013).   
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Table 1.2: Classification of phytochemicals explained according to subtype, chemical structure, examples, and sources alongside 
additional information to understand each type (continued on page 29). 
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Table 1.3: Classification of flavonoids, divided into their subtypes, chemical structure, 
examples and structure. 
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RATIONALE 
 
The aim of this project was to measure the phytochemical and antioxidant levels of a 
variety of fruits: strawberry, cranberry, acai berry, maqui berry and goji berry, to determine 
their chemotherapeutic effects alone and in combination with current therapies within 
human cell lines - human brain glioblastoma, astrocytoma; classified as grade IV compared 
to human foetal astroglia as a control for the treatment of glioma. These five particular 
fruits were chosen due to emerging claims promoting their health benefits being advertised 
to the public due to their high antioxidant levels and their current frequency in the regular 
diet in freeze dried form. 
 
Initial studies focussed on determining the presence of particular polyphenolic compounds 
present with the fruit samples via the conduction of High Performance Liquid 
Chromatography (HPLC). The abundance of phytochemicals within each fruit extract were 
identified with the use of previously optimised flavonoid and phenolic assays.  Further 
characterisation of the antioxidant effects were measured by 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) method.  Following this, the mechanism of action of cell death in glioma cells was 
measured by cell viability, cell cycle, proliferation, apoptosis and metabolic assays in 
increasing concentrations. 
  
Cell culture studies were performed alone and compared with current chemotherapeutic 
agents used in the treatment of glioma, namely cisplatin in cell viability, cell cycle, 
proliferation and apoptosis assays.   
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HYPOTHESIS AND AIMS 
 
Working Hypothesis: Can polyphenolic compounds found in cranberry, strawberry, goji 
berry, maqui berry and acai berry become a potential chemotherapeutic agent in in vitro 
models of glioma? 
 
Main Aim: The main aim of this study was to analyse fruit extracts, determine the 
composition of antioxidants and study their effects on glioma cell lines. 
 
Specific Aims:  
 
1. To determine the composition of antioxidants present within freeze-dried cranberry, 
strawberry, goji berry, maqui berry and acai berry. 
 
2. To determine the total flavonoid, total phenolic and total antioxidant capacity of the 
five fruit extracts. 
 
3. To investigate the time course and dose dependant effects of cisplatin, antioxidants 
and the five fruit extracts on glioma cell lines. 
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Chapter 2 
METHODS AND MATERIALS
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2.1 Chemicals and Plastics 
All chemicals used were of the highest quality available. 
 
Scientific Laboraestory Supplies (Nottingham, UK) 
Sodium nitrite (NaNO2), aluminium chloride (AlCl3), sodium hydroxide (NaOH), 2N 
Folin-Ciocalteu’s reagent, sodium carbonate (Na2CO3), gallic acid, (+) catechin hydrate, 
2,2-diphenyl-1-picrylhydrazyl (DPPH) and (±)-6-hydroxy-2,5,7,8-
tetramethylchromane-2-carboxylic acid (TROLOX) 
 
Fisher Scientific, (Loughborough, UK) 
HPLC Grade methanol, 96 well plates, PBS tablets, 25 and 75 cm2 filter cap, angled 
neck tissue culture flasks, serological pipettes, 50 and 15 ml centrifuge tubes, multi-well 
plates and Foetal Bovine Serum, 20ml syringes 
 
BMG LABTECH (Offenburg, Germany) 
FLUOstar OPTIMA plate reader 
 
Sigma Aldrich (Poole, UK) 
SUPELCO Analytical LC18, 5µm, 25cm x 4.6mm column, (+) catechin hydrate, gallic 
acid, myricetin, elagic acid, kaempferol, quercetin, green tea catechin mix, punicalagin 
and 2 ml vials with screw tops, Trypan blue, cisplatin and DMSO 
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Greyhound Chromatography (Merseyside, UK) 
Cyanidin chloride, malvidin chloride, deplphinidin chloride and pelargonidin chloride 
 
Chemfaces (Hubei, Wuhan, China) 
Cyanidin-3-O-glucoside chloride 
 
Agilent Technologies (Waldbronn, Germany) 
Agilent Technologies Series 1200 system: G1322A degasser, G11311A quaternary 
pump, G1329A standard auto sampler, G1316A thermostatted column compartment, 
G1315D diode array detector and multi wavelength detector and G1159A six position 
column selector valve.  
 
Life Technologies (Paisley, UK) 
PrestoBlue® Cell Viability Reagent 
 
Lonza (Slough, UK) 
Eagle’s MEM w/o L-Glut, NEAA (100x), L-Glutamine (2mM), Trypsin (10x) and 
sodium pyruvate (100mM) 
 
ECACC (Porton Down, UK) 
U-87 MG Grade IV Human Glioblastoma cell line 
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ATCC (Masassas, VA, USA)  
SVG-P12 human foetal astroglia cell line 
 
www.healthysupplies.co.uk: Healthy Supplies & Sussex Wholefoods (Lancing, 
West Sussex, UK) 
Freeze-Dried Strawberry Powder (100g), Freeze-Dried Cranberry Powder (100g), Goji 
Juice Powder - organic (150g), Freeze Dried Maqui Berry Powder - organic (100g), 
Freeze-Dried Acai Berry Powder- Organic (100g)   
GE Healthcare Life Sciences (Buckinghamshire, UK) 
Puradisc™ 25mm Sterile and Endotoxin Free 0.2µm PES Filter Media 
 
2.2. Sample Preparation 
 
The fruit samples used within experimentation were prepared with the mind – set of the 
consumer. This was defined by interpreting the serving suggestions given by the 
manufacturer: 
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Table 2.1: description of fruit sample preparation. Each fruit had serving 
suggestions which were applied to the sample preparation in accordance to the 
experiments conducted in order to obtain results as per these serving suggestions. 
Fruit Serving Suggestions Fruit sample (g) Solvent (ml) 
Cranberry 1:5 ratio of powder to liquid 1.29 25 
Strawberry 1:5 ratio of powder to liquid 1.48 25 
Goji berry 2 tsp in 250 ml 2.69 250 
Maqui berry 2 tsp in 250 ml 4.11 250 
Acai berry 2 tsp in 250 ml 5.39 250 
 
 
2.3. High Performance Liquid Chromatography (HPLC) 
 
The fruit samples, cranberry, strawberry, goji berry, maqui berry and acai berry were 
weighed out in accordance to their serving suggestions and dissolved in HPLC grade 
methanol and filtered using a 0.2 µm filter (Table 2.1). These were compared against 
the 12 standards consisting of catechin, quercetin, myricetin, kaempferol, punicalagin, 
ellagic acid, gallic acid, cyanidin, cyanidin-3-glucoside, delphinidin, malvidin, 
pelargonidin. All standards were prepared as 1mg/ml and were stored at -20°C. Two 
HPLC methods were preliminarily explored with the use of an Agilent Technologies 
Series 1200 system consisting of a degasser, quaternary pump, standard auto sampler, 
thermostatted column compartment, diode array detector and multi wavelength detector 
and a six position column selector valve.  
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2.3.1 HPLC: Method 1 
 
All standards and samples were analysed following a gradient elution programme 
(modified from Huang et al., 2012). This required solution A, 0.1% formic acid, and 
solution B, 100% methanol. This was used to follow a graduated method consisting of: 
0-10 min,  where solution B was increased from 0%–10%; at 10–25 min, solution B was 
increased from 10%–20%; at 25–35 min, solution B increased from  20%–23%; at 35–
45 min, solution B increased from 23%–28%; at 45–60 min,  solution B increased from 
28%–35%; at 60–75 min, solution B increased from 35%–50%; at 75–80 min, solution 
B increased from 50%–55%; at 80–85 min, solution B increased from 55%–75%; at 85–
90 min, solution B increased from 75%. The flow rate was 0.8 ml/min and the injection 
volume was 20 μl. Detection was monitored at 280 nm. 
 
2.3.2 HPLC: Method 2 
 
All standards and samples were analysed following a method modified from Brauch et 
al., 2016. Elution solvent A consisted of water/methanol/formic acid (77/13/10), while 
solvent B was a mixture of water/methanol/formic acid (30/60/10). Separation was 
achieved using: 0-15 min, 6% (solvent B), increased to 30% (solvent B), 15-20 min, 
30% - 36% (solvent B), 20-25 min, 36%- 100% (solvent B), 25-27 min, 2 min isocratic 
period, 27-30 min, 100% - 6% (solvent B), 30-35 min, re-equilibration at 6% (solvent 
B). Total run time was 35 min at a flow rate of 0.8 mL/min. The injection volume was 
10µl. Samples were monitored at 520 nm. 
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2.3.3 Identification of Phytochemicals in Fruit Extracts 
 
Running the HPLC methods gave an indication of what could be present within the fruit 
extracts. To seek confirmation of what was observed, the process of spiking was 
undertaken. Spiking was the process in which a standard antioxidant was added to a 
fruit sample to determine the presence of that antioxidant within the fruit extract. This 
was expressed as a larger peak on the resulting chromatograms. Fruit extracts and 
standards were prepared in a 1:1 ratio and subjected to HPLC using a modified version 
of method 1. 
 
 
2.3.4 Quantification of Phytochemicals in Fruit Extracts 
 
The determination of the presence of antioxidants within the fruit samples led to the 
progression of quantifying this. This was achieved by creating a standard curve per 
relevant antioxidant against which each fruit sample could be quantified. This was 
accomplished by serial, 1:2 dilutions of the antioxidant standard from 1mg/ml to 0.0009 
mg/ml. From this, it was possible to interpolate the amount of antioxidant present within 
the fruit sample. 
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2.4. Determination of Phytochemical Content and 
Antioxidant Capacity of Fruit Extracts 
 
The fruit samples, cranberry strawberry, goji berry, maqui berry and acai berry were 
prepared as recommended by the serving suggestions (Table 2.1) and dissolved in 
dH2O. 
 
2.4.1 Measurement of Total Phenolic Content  
 
The total phenolic content (TPC) was determined using a modified Folin-Ciocalteu 
method (Yang et al., 2012).  Samples consisted of undiluted and diluted, in dH2O, at 
1:10, 1:100 and 1:1000 using serial dilutions and 12.5μl was added in triplicate to the 
wells, incubated with 62.5μl of a master mix containing 50μl dH2O and 12.5μl of 1N 
Folin- Ciocalteu reagent for 5 minutes at room temperature. 125µl of 7% Na2CO3 was 
added per well and samples incubated for 30 minutes at room temperature. Absorbance 
was measured at 750nm. TPC was quantified using a standard calibration curve, 
prepared using 0.5mg/ml gallic acid in dH20, and expressed as mg of gallic acid 
equivalents (GAE)/ml of sample (Appendix 2.2). 
 
2.4.2 Measurement of Total Flavonoid Content 
 
The total flavonoid content (TFC) of the samples was determined using a modified 
AlCl3 method (Marinova et al., 2005). Samples consisted of undiluted and diluted, in 
dH2O, at 1:10, 1:100 and 1:1000 using serial dilutions and 20μl added in triplicate to the 
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wells. 6μl of 5% NaNO2 and 80μl of dH2O added to each well and incubated for 5 
minutes, after which 94μl of a master mix containing 6μl 10% AlCl3, 40μl 1M NaOH 
and 48μl of dH2O was added and the absorbance was measured at 510nm. The TFC of 
the samples was quantified using a standard calibration curve, prepared using 1mg/ml 
catechin in dH2O, and expressed as mg of catechin equivalents (CE)/ml of sample 
(Appendix 2.1). 
 
2.4.3 DDPH Radical-Scavenging Capacity 
 
The antioxidant capacity (AC) was determined by the DPPH· radical scavenging 
method modified from Kodama et al., (2012) and Thaipong et al., (2006). Samples 
consisted of undiluted and diluted, in MeOH on ice, at 1:10, 1:100 and 1:1000 using 
serial dilutions. 50μl of sample was incubated with 250µl of 0.5mM DPPH per well for 
20 minutes at room temperature. Absorbance was measured at 515nm. AC was 
quantified using a standard calibration curve, prepared using 1mM TROLOX in MeOH 
and expressed as μM TROLOX equivalents (TE)/ ml of sample (Appendix 2.3.1). 
Percentage scavenging was also calculated using a standard calibration curve (Appendix 
2.3.2). 
 
2.5 Cell Culture 
 
Fruit samples, cranberry, strawberry, goji berry, maqui berry and acai berry were 
prepared in accordance to the serving suggestions and dissolving in media, in sterile 
conditions in a Labcaire laminar flow hood. 
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2.5.1 Cell Maintenance 
 
U-87 MG and SVG-p12 cells were maintained in EMEM supplemented with, Foetal 
Bovine Serum, L-Glutamine (2mM), NEAA (1%), and sodium pyruvate (1mM) in an 
environment of 37oC and 5% CO2 atmosphere within an IncuSafe incubator. Upon 
confluency of cells at approximately 80%, cell monolayers were washed with 3ml PBS 
solution, replaced with 2ml trypsin and the flask was returned to the incubator to allow 
the cells to detach. After detachment, 4ml of the supplemented EMEM (media) was 
added to the flask to neutralise the trypsin. The cells were gently pipetted to ensure a 
single cell suspension was obtained before passaging into suitable ratios or seeded into 
plates for experimental analysis. 
 
2.5.2 Growth Curves 
 
In order to determine the growth rate of the cell lines, performed over seven days. 6 well 
plates were seeded with 20,000 cells/ml and topped with 2ml media. Cells were 
trypsinised and the cell number was determined by manually counting the cells with the 
use of a haemocytometer on 2-5 days, with an interval of 2 days and then read on the 
7th day. This process was repeated in triplicate.   
 
2.5.3 Presto Blue® Cell Viability Assay 
 
Concentration dependent effects of each treatment on cell viability were measured by 
the addition of PrestoBlue®, resulting in a resazurin reduction by metabolically active 
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cells, changing in colour from blue to red (absorbance 570 nm) and becoming highly 
fluorescent (excitation 535 nm/ emission 612 nm), over a 7 day period and repeated in 
triplicate. Thus, allowing it to be possible to quantify changes. This was accomplished 
by expressing viability via linearity of fluorescence versus cell number. Cells were 
seeded at 0, 500, 1000, 2000, 2500, 5000 and 10,000 cells/ well per 100µl of media in 
96-well plates. These plates were then left to incubate over a period of 7 days within 
normoxic and hypoxic conditions.  
 
After 24, 48, 72, 96 and 120 hrs of incubation, 10 µl of PrestoBlue® was added to each 
well and the plate was returned to incubate for one hour after which the fluorescence 
was obtained by the Tecan GENius PRO plate reader. 
 
2.5.4 Concentration Response Curves 
 
The concentration response assay was conducted to determine the IC50 values for 
cisplatin, punicalagin, cyanidin-3-glucoside, cranberry, strawberry, maqui berry and 
acai berry fruit samples in SVG-p12 and U-87 MG cells in normoxic conditions.  
This was accomplished by seeding cells at 1000 cells/ well in 100 µl media and 
incubated for 24 hours before (11 µl) drug treatments were added (ranging from 1µM- 
300µM) in order to determine the dose response. This was left to incubate for another 
24 hours before 10µl of PrestoBlue® was added for the fluorescence to be measured 
one hour later at the same wavelength as the cell viability assay. 
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2.6. Statistical Analysis 
 
Statistical analyses were performed using Microsoft Excel 2013, GraphPad Prism 5 and 
IBM SPSS Statistics Version 22. Fruit samples were compared by performing one-way 
and two-way ANOVA tests with Tukey’s and Gabriel’s post- hoc analysis on SPSS and 
GraphPad Prism 5, with p<0.05 considered as indicating a statistically significant 
difference. Results were expressed as an average ± the Standard Deviation or ± the 
Standard Error of Mean (SEM) where appropriate. HPLC used ChemStation to aid in 
the analysis of chromatograms. 
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Chapter 3 
RESULTS 
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3.1 High Performance Liquid Chromatography 
3.1.1 Comparison of HPLC Methods for Sample Separation 
 
 
Based on previously published protocols, investigations into the phytochemical 
composition of the five fruit samples were undertaken using two different graduated 
HPLC methods. Method 1 comprised of a 90 minute run time with a mobile phase of 
methanol and 0.1% formic acid and read at 280 nm. Method 2 consisted of a 30 minute 
graduated method with a mobile phase of two solvent mixtures containing water: 
methanol: formic acid in the ratios of 77:13:10 (Solvent A) and 30:60:10 (Solvent B).  
Peaks in method 2 were detected at 520nm.  Method 2 had been demonstrated 
previously to be optimal for detecting anthocyanidins in fruit samples and so was of 
particular interest for this study.  
 
Initial investigations using HPLC Method 1 showed an elution time for the fruit samples 
of between 3.38 ± 0.28 - 3.59 ± 0.06 mins (Figure. 3.1 and Table 3.1).  All of the 
standards used were eluted from the column within 3.00 ± 0.90 – 84.27 ± 2.04 mins 
except catechin, quercetin, myricetin and kaempferol, which did not show discernible 
peaks using this method (Table 3.1).  Comparison of the traces and peak elution times 
suggested that the fruit samples may contain punicalagin (3.46 ± 0.45 mins), gallic acid 
(3.35 ± 0.11 mins), cyanidin-3-glucoside (3.33 ± 0.15 mins) and malvidin (3.47 ± 0.04 
mins) (Table 3.1). 
 
Method 2 showed elution times between 4.04 ± 0.00 mins (maqui berry) and 4.66 ± 
0.03 mins (strawberry) for the fruit extracts (Figure. 3.2).  The standards showed a more 
wide-ranging elution rate ranging from 4.23 ± 0.01mins (cyanidin-3-glucoside) to 27.75 
± 2.7 mins (malvidin) (Table 3.2).  Based on these results, and as this method was 
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known to be favourable for separating anthocyanidins, it was suggested that the samples 
contained only cyanidin-3-glucoside which had shown a retention time of 4.23 ± 
0.01mins (Table. 3.2). 
 
3.1.2 Identification of Phytochemicals Present in Fruit Extracts 
 
 
Having identified a number of antioxidants which may have been present in the fruit 
extracts, further investigation was undertaken.  Fruit extracts and standards were 
prepared in a 1:1 ratio and subjected to HPLC using Method 1.  This process of 
‘spiking’ the samples with the addition of a known reference material can help to 
confirm the identity of the sample component peaks. 
 
Each fruit extract was mixed with punicalagin, gallic acid, cyanidin-3-glucoside or 
malvidin.  As the retention times for the extracts and standards was within the first 5 
minutes, the run time for Method 1 was decreased to 20 mins.  
 
Analysis of the spiked samples showed an increase in the height of the peaks detected 
on the chromatograms with no additional peaks observed (Figure. 3.3).  Retention times 
for the spiked samples were comparable to those obtained from the fruit extracts and 
standards alone (Table 3.3) indicating that punicalagin, gallic acid, cyanidin-3-glucoside 
and malvidin could be present in the fruits investigated. This demonstrated that there is 
tentative evidence that punicalagin, cyanidin-3-glugoside, and malvidin could be 
present within the fruit extracts. 
 
3.1.3 Quantification of Phytochemical Components used with the 
HPLC system and comparison of Fruit Extracts between HPLC, TFC 
and TPC 
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Having determined the presence of 4 antioxidant compounds within each of the fruit 
extracts, a standard curve was generated in order to measure the amount of each 
compound in each extract. Decreasing concentrations of the standards (1 – 0.0009 
mg/ml) were run through HPLC using Method 1. The minimum amount of standard that 
could be reliably detected was determined (limit of detection; LOD) and plotted as 
concentration vs average peak area (Figure 3.4) thus expressing the validity of the 
system used. 
 
From this, we were able to use the peak areas from the fruit extracts obtained from the 
HPLC method 1 and compare them to the results obtained from the TFC and TPC 
assays. This showed similarities where by the  
 
3.2 Determination of the Phytochemical Content and 
Antioxidant Capacity of Fruit Extracts 
 
Phenolics are products of secondary metabolism in plants and provide essential 
functions for the maturation and reproduction. They are compounds which have one or 
more aromatic benzene rings, with one or more hydroxyl groups attached to it.  The 
phenolics are further divided into 5 subgroups according to the number of phenol rings 
that they contain and the structural elements that bind these rings to one another. 
Flavonoids, the largest sub-group of phenolics, have been shown to possess antioxidant, 
anti-proliferative and anti-inflammatory activity. 
The therapeutic potential of plants can be measured by a variety of parameters including 
the ratio of flavonoid to phenolic compounds present in the extract, and the overall 
antioxidant activity observed.  The ratio of flavonoids to overall phenolic content in 
plant extracts, in combination with the measurement of the antioxidant capacity of these 
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extracts can be used as an indicator of the therapeutic potential of these compounds.    
Having identified the presence of antioxidant compounds within the fruit extracts, total 
phenolic, total flavonoid and overall antioxidant capacity was measured.   
 
3.2.1 Total Phenolic and Total Flavonoid Content 
 
To determine the total phenolic content (TPC) of the fruit extracts, a modified Folin-
Ciocalteu assay was used (Section 2.4.1).  The average TPC ranged from 281.55 ± 6.97 
(goji berry) to 2835.11 ± 26.48 (strawberry) mg/ml GAE as calculated for a ‘serving’ as 
specified by the manufacturer (Table 3.5; Figure 3.6; Section 2.4). Within these 
samples, a significant difference was found (p<0.001) in the range of TPC values (Table 
3.6). A Tukey’s post hoc analysis revealed a significant difference in the mean TPC 
between: cranberry and strawberry and goji berry (p<0.05); strawberry and all fruit 
extracts (p<0.05 cranberry; P<0.001) as shown in table 3.7. 
 
Using a modified AlCl3 method (Section 2.4.2), total flavonoid content (TFC) of each 
extract was quantified.  The TFC of the extracts was found to range from 166.37 ± 
33.38 (goji berry) to 670.93 ± 45.30 µg/ml CE (cranberry) per serving (Table. 3.5; 
Figure 3.5; Section 2.2).  Significant differences (p<0.001) in the TFC were found 
between all fruit extracts (Table 3.6). Further analysis identified the most significant 
differences in the mean TFC between: cranberry and goji berry (p<0.05); cranberry and 
acai berry (p<0.05) was observed (Table 3.7). 
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3.2.2 Flavonoid to Phenolic Ratio 
 
Although flavonoids are the most abundant phenolic, there are four other sub-groups 
present within this classification. Therefore, the flavonoid to phenolic ratio expresses 
the TFC as a proportion of the TPC. The flavonoid to phenolic ratio states the 
proportion of flavonoids that make up the phenolic content within the fruit extracts.  
The flavonoid: phenolic ratio ranged from 0.14 in strawberry to 0.59 in goji berry.   This 
ratio is expressed for all the fruits extracts as shown is table 3.5. 
 
3.2.3 Total Antioxidant Capacity 
 
 
Following determination of a high ratio of flavonoid to phenolic compounds in a 
number of the fruit extracts, the antioxidant capacity (AC) of each fruit was measured.   
The AC of the compounds previously identified by HPLC as being present in the fruit 
extracts were also measured in parallel (gallic acid, punicalagin, cyanodin-3-glucoside 
and malvidin).   Using the DPPH· radical scavenging method (Section 2.4.3), the 
average AC as shown in table 3.8 was found to range from 2239.07 ± 1021.27 
(cranberry) to 16.84 ± 82.60 mM TE (goji berry) per serving (p<0.001) (Figure 3.7; 
Table 3.9). Table 3.9 shows that the Gabriel’s post hoc test for the DPPH assay revealed 
a significant difference in the mean AC between: cranberry and strawberry, goji berry, 
and punicalagin (p<0.05, excluding maqui berry, acai berry, gallic acid, cyanidin-3-
glucoside and malvidin, p<0.001). 
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3.3. Cell Culture 
3.3.1 Growth Curves 
 
Proliferation and the conditions in which it occurs are factors influencing cell growth. 
This affects any lag periods or plateaus in growth following prolonged incubation of 
SVG-p12 and U87-MG cells. In this case, growth curves were performed in conditions 
of normoxia and hypoxia over a period of 7 days. Both cell lines expressed an 
exponential growth over a period of seven days, displaying signs of a lag phase over the 
first 48 hours (Figure 3.8). A significant difference was found between the incubation 
conditions of normoxia and hypoxia within both cell lines at 168 hours (p<0.001). 
 
3.3.2 Cell Viability 
 
 
The relationship between fluorescence and cell number as measured by the PrestoBlue® 
viability assay was determined by an assay using increasing numbers of cells (Section 
2.5.4)).  SVG-p12 and U87-MG cell lines displayed a linear relationship between 0-24 
hours between 0-10,000 cells. However, following this at 48 hours, fluorescence was 
linear to 2,500 cells and 72 - 168 hours a linearity is only present between 0-1000 cells 
(Figure 3.9). 
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3.3.3 Dose Response Curves 
 
 
The results obtained from the TAC, indicated punicalagin and cyandin-3-glucoside to 
contain the highest AC as measured by the radical scavenging activity. Conversely, goji 
berry consistently showed low levels of potential antioxidants throughout the study. 
Therefore, punicalagin and cyandin-3-glucoside were taken forward for in vitro analysis 
of their activity. Of the fruits, goji berry was not analysed further. Concentration 
response assays were undertaken in SVGp12 and U87-MG cell lines to establish the 
IC50 values for the fruit extracts, the previously identified standards punicalagin and 
cyanodin-3-glucoside and the standard chemotherapeutic agent, cisplatin.  
 
Following treatment with cisplatin, a reduction in cell viability was observed in SVG-
p12 and U87-MG cell lines at 24hrs (37.04 µM vs10.82 µM), 48hrs (10.11 µM vs 7.13 
µM) and 72hrs (9.42 µM vs 1.94 µM). Punicalagin showed SVG-p12 and U87-MG IC50 
values at; 24 hrs (85.42 µM vs 149.90 µM), 48 hrs (48.56 µM vs 45.55 µM) and 72 hrs 
(46.50 µM vs 57.11 µM). Cyanidin-3-glugoside displayed a decrease in cell viability in 
both cell lines at 24hrs (103.60 µM vs 101.30 µM), 48hrs (109.40 µM vs 46.24 µM) 
and 72hrs (36.65 µM vs 31.43 µM). Further analysis found there to be a significant 
difference between cyanidin-3-glucoside and cisplatin and punicalagin (p<0.001) in 
SVGg-p12 cells (Figure 3.10 and Table 3.10).  
 
In addition, concentration response assays were conducted with fruit extracts prepared 
at 1mg/ml in EMEM (Section 2.2). IC50 values for cranberry showed a decrease in cell 
viability at 24hrs (3.88 mg/ml). In the U87-MG cell line, IC50 values at 48hrs (0.13 
mg/ml) and 72 hrs (0.01 mg/ml). Strawberry at 48 hours in SVG-p12 resulted in an IC50 
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value of 0.11 mg/ml. U87-MG showed IC50 values at 24 hrs (0.24 mg/ml), 48 hrs (3.43 
mg/ml) and 72 hrs (0.01 mg/ml) when strawberry was added to the cell line. Maqui 
berry had an IC50 value of 0.001 mg/ml at 72 hrs in SVG-p12 cells (Figure 3.11 and 
Table 3.11).  Further analysis from this expressed a significant difference between 
maqui and cranberry (p<0.001 at 24, 48 and 72 hrs); maqui and strawberry (p<0.001 at 
24 and 48 hrs); and maqui and acai berry (p<0.001 at 24 and 48 hrs; p<0.05 at 72 hrs) in 
the SVG-p12 and U87-MG cell lines. 
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Figure 3.1 (A-F): Example of Chromatograms of fruit samples obtained from 
method 1. Fruit samples obtained from Method 1; A. cranberry- entire 
chromatogram; B. cranberry; C. strawberry; D. goji; E. maqui; F. acai. These samples 
were run on a 90 minute graduated method alongside 12 standards. Results shown were 
obtained from one independent experiment. 
 
 
Table 3.1 (A & B): Average retention times, peak areas and percentage peak areas 
for all standards (A) and samples (B) obtained using Method 1. Average retention 
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times, peak areas and percentage peak areas were obtained from two independent 
experiments (A). The averages for the fruit samples were obtained from the biggest 
peak found from two independent experiments. This information led to the possibility of 
punicalagin, gallic acid, cyanidin-3-glucoside and malvidin to be present within the fruit 
samples.   
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Figure 3.2 (A-E): Zoomed chromatograms of fruit samples obtained from Method 
2. Fruit samples obtained from method 1; A. cranberry – entire chromatogram; B. 
cranberry; C. strawberry; D. goji; E. maqui; F. acai. These samples were run on a 30 
minute graduated method alongside 12 standards. Results shown were obtained from 
one independent experiment. 
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Table 3.2 (A & B): Average retention times, peak areas and percentage peak areas 
for all standards (A) and samples (B) obtained from Method 2. Average retention 
times, peak areas and percentage peak areas were obtained from two independent 
experiments (A). The averages for the fruit samples were obtained from the biggest 
peak obtained from two independent experiments. This information led to the 
possibility cyanidin-3-glucoside to be present within the fruit samples.  
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Figure 3.3 (A-D): Zoomed chromatograms of spiked samples obtained from 
method 1 as compared to non-spiked sample. Example of fruits spiked with 
compounds obtained from method 1; A. Cranberry; B. Cranberry + punicalagin; C. 
Cranberry + gallic acid; D. Cranberry + cyanidin-3-glucoside; E. Cranberry + malvidin. 
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Table 3.3: Average retention times spiked samples obtained from Method 1. Average retention times and peak areas were obtained from two 
independent experiments. Percentage presence represents the percentage increase in the peak areas of the fruit sample compared to the corresponding 
standard, once the samples were spiked. 
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Figure 3.4 (A-D): Standard curves of compounds obtained via LOD from Method 
1. Standard curve used to quantify the concentration of the compounds; A. Punicalagin 
(a positive correlation was observed between peak area and concentration at r2=0.93); 
B. Gallic Acid; (a positive correlation was observed between peak area and 
concentration at r2= 0.99) C. Cyanidin-3-glucoside (a positive correlation was observed 
between peak area and concentration at r2= 0.99); D. Malvidin (a positive correlation 
was observed between peak area and concentration at r2= 0.89) within the fruit samples 
expressed as mg/ml. 
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Fruit Fruit Sample Average Peak area Total Flavonoid Content Total Phenolic Content 
                            (mAU) Avg µg/serving Catechin  Avg µg/serving Gallic acid 
Cranberry 15145.05 ± 427.45 670.93 ± 45.30  1439.16 ± 7.59  
Strawberry 20876.90 ± 3319.44 394.72 ± 39.09  2835.11 ± 26.484  
Goji berry 4615.724 ± 869.16 166.37 ± 33.38  281.55 ± 6.97  
Maqui berry 9818.40 ± 518.87 427.83 ± 151.46  1104.52 ± 23.32  
Acai berry 857.86 ± 279.11 251.57 ± 52.45  851.60 ± 18.17  
Table 3.4: Comparison between the average peak areas of the fruit extracts and the TFC and TPC. The HPLC values were obtained from n=2 of 
HPLC method 1; TFC and TPC values were expressed as µg/serving Catechin and µg/serving Gallic acid from n=3 independent experiments. The TFC 
and TPC values are also expressed individually in figures 3.5 and 3.6. 
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Figure 3.5: Shows the total flavonoid content results obtained for each fruit extract 
 
 
 
Figure 3.6: Shows the total phenolic content results obtained for each fruit extract 
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Figure 3.7: Shows the antioxidant capacity and the percentage scavenging results obtained via the DPPH assay for each fruit type within each 
fruit form in ascending order. 
T.E =  TROLOX equivalence
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Table 3.5: Total Flavonoid Content, Total Phenolic Content, Flavonoid to Phenolic 
Ratio and Total Antioxidant Capacity: TFC per fruit extract expressed as µg/serving 
catechin equivalence; TPC per fruit extract expressed as µg/serving gallic acid 
equivalence; flavonoid to phenolic ratio as obtained from n=3 independent experiments. 
 
 
 
 
 
Table 3.6: One- way ANOVA for antioxidant activity: Showing the degrees of 
freedom (df), mean square and p values within each antioxidant assay; total flavonoid 
content, total phenolic content and DPPH.    
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Table 3.7: Post hoc analysis: A Tukey’s post hoc analysis was conducted to show the 
difference between the fruit extracts within total flavonoid and total phenolic content. 
n.s. = No Significant Difference. a = TFC, b = TPC   
 
 
 
Table 3.8: Total antioxidant capacity of fruit extracts and antioxidants. Total 
antioxidant capacity for each sample was expressed as µM/serving TROLOX 
equivalence as obtained from n=6 independent experiments. 
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Table 3.9: Post hoc analysis for DPPH assay. A Gabriel’s post hoc analysis was conducted to show the difference between the fruits within the total 
antioxidant capacity assay. 
n.s. = No significant difference 
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Figure 3.8: Growth rate for SVG –p12 and U87 MG cells. Upon initial seeding of 
20,000 cells per well, proliferation was determined by a manual cell count of a seven 
day period.SVG-p12 demonstrated a doubling time of approximately 30-72 hours. U87-
MG demonstrated a doubling time of 30-42 hours. The data illustrates mean cell 
number ± SEM generated from n=3. 
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Figure 3.9: The relationship between fluorescence and increasing cell number for 
SVG –p12 (A) and U87 MG (B) cells. The data illustrates ± SEM generated from three 
independent experiments per cell line.   
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Figure 3.10 (A-F): Graphs illustrating the effect of dose-dependent treatment on of cisplatin, punicalagin, and cyanidin-3-glucoside on SVG-
p12 and U87-MG cell lines. A-C display the dose – dependent effect of the three compounds on the SVG-p12 cell line over 24, 48 and 72 hours 
respectively. D-F display the dose – dependent effect of the three compounds on the U87-MG cell line over 24, 48 and 72 hours respectively.  The data 
illustrates ± SEM generated from n=3 experiments per cell line.   
D E F 
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Figure 3.11 (A-F): Graphs illustrating the effect of dose-dependent treatment on of cranberry, strawberry, maqui berry and acai berry on 
SVG-p12 and U87-MG cell lines. A-C display the dose – dependent effect of the three compounds on the SVG-p12 cell line over 24, 48 and 72 hours 
respectively. D-F display the dose – dependent effect of the three compounds on the U87-MG cell line over 24, 48 and 72 hours respectively. . The 
data illustrates ± SEM generated from n=3 experiments per cell line.   
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Table 3.10 (A & B): IC50 values for SVG-p12 cell line (A) and IC50 values for U87-MG cell line (B) following 24, 48 and 72 hours incubation 
with cisplatin, punicalagin and cyanidin-3-glucoside. 
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Table 3.11: IC50 values for SVG-p12 cell line and U87-MG cell line following 24, 48 and 72 hours incubation with cranberry, strawberry, 
maqui berry and acai berry fruit extracts. 
 
 
 
72 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 
DISCUSSION 
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4.1 Discussion 
Due to increasing media influences surrounding healthy lifestyle choices and the claims 
that berries such as maqui and goji contain high levels of antioxidants, this study 
investigated the levels of potential antioxidant compounds within freeze-dried extracts 
of strawberry, cranberry, maqui, goji and acai berries; and their potential to be used as   
alternative therapies for the treatment of glioma.  
 
These five fruits were of particular interest for this study due to the increasing level of 
media coverage they have received over the past 2-3 years. The fruits themselves, as 
well as products containing these fruits are heavily promoted via blogs and websites 
stating information regarding how these berries benefit health 
(www.purehealingfoods.com; www.globalhealingcentre.com). In addition to this, the 
NHS, a trusted public resource within the UK, provides information regarding 
superfoods, and in particular, goji berries (NHS Choices, 2015). Products such as 
powder mixes are also advertised to the general public which are aimed at those who 
take an interest in healthy living, claiming to ‘contribute to normal immune and nervous 
system function’ (www.myprotein.com). Due to the unavailability of the fresh fruit in 
the UK, the uncommon fruits such as maqui and acai berries are readily available online 
and particularly, within freeze dried forms. This form is claimed to retain the benefits of 
fresh fruit, particularly when referring to the presence of antioxidants 
(www.HealthySupplies.co.uk; www.Lio-Licious.com; www.MamasHealth.com).  
 
The aim of this study was therefore to investigate the claims made within public forums 
suggesting that these berries contain higher levels of antioxidants than other fruits, and 
therefore bestow greater health benefits to the consumer. To maintain similarity to the 
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end user, the freeze-dried powders used within the study were prepared according to the 
serving suggestions advertised to the consumer, accounting for the requirements of the 
experiment being conducted. 
 
4.2 HPLC 
 
HPLC analysis provided an indication of the presence of antioxidants within the chosen 
fruit extracts. Due to the preliminary nature of this analysis, the presence of antioxidants 
was identified by comparing the fruit extracts to a range of the most abundant 
phytochemicals within the phenolic subtype in particular, phenolic acids, flavonols and 
anthocyanidins.  
 
Initial HPLC studies were performed using a protocol optimised for the separation of 
strawberry samples. The strawberry extract was found to contain a number of 
phytochemicals as previously reported, confirming the suitability of this method for 
sample separation within our system (Huang et al., 2012).  Ideally the protocol for 
separation of each berry would have been optimised however, as this was not the sole 
purpose of this study, and the fact that not all fruits had an associated published 
protocol, each fruit sample was analysed using the strawberry protocol. The results 
concluded that the strawberry extract contained the highest number of antioxidants as 
compared to all other fruit extracts measured however, this may have been influenced 
by the fact that the method used was optimised for this particular berry. 
In addition, as the berries chosen for this study are known to contain high levels of 
anthocyanidins, contributors to the bright red, blue and purple colours of fruits and 
vegetables; a protocol optimised for this phenolic subgroup was also investigated 
(Wang and Stoner, 2008; Aabay et al., 2007; Brauch et al., 2016). On comparison of the 
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separation of the samples using the two protocols, it was found that there was no 
enhanced separation of anthocyanidins and confirmed that strawberry extract contained 
the highest amount of antioxidants; suggesting that the strawberry protocol was suitable 
for this study.  Furthermore, the fruit extracts tested, displayed similar results to 
previously published studies showing the presence of gallic acid, punicalagin and 
cyanidin-3-glucoside (Thermo Scientific., 2012).  
 
It was evident from comparison to the literature that a varying level of sensitivity exists 
within HPLC. Antioxidants such as cyanidin can exist with attached moieties for 
example, glucose or galactose, which contribute to the antioxidant capacity of the 
compound.  These small differences in the structure of the compound can be detected by 
altering the HPLC conditions such as solvent, solvent ratios, column type and 
temperature.  Upon further optimisation of the protocol, there may have been potential 
to distinguish these structural differences. 
 
In an attempt to confirm the peaks seen were those of the antioxidant standards, samples 
were spiked.  A single, higher peak at the same retention time suggests that the sample 
contains the compound of interest.  In order to absolutely define the compound present 
within the sample, further experimentation could be performed. A previous study used 
gas chromatography-mass spectrometry (GC-MS) to identify polyphenolic compounds 
within a root extract (Ajayi et al., 2011). This process consisted of using GC to separate 
compounds to a greater degree of resolution however, this alone does not achieve an 
identification of the compound. In combination with MS, which has the ability to 
identify compounds through their molecular weight, detailed structural information can 
be obtained, which has the potential to identify a compound.  
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4.3 Flavonoid: Phenolic Ratio and Antioxidant Capacity 
 
Following the identification and quantification of the polyphenolic compounds within 
the fruit extracts, it was important to recognise the type of antioxidants that were 
contributing to this activity. The flavonoid to phenolic ratio (F: P) was calculated to 
quantify the amount of flavonoid present in the total phenolic content of each fruit 
extract. As flavonoids are a subgroup of phenolics, the F: P ratio determines how much 
the flavonoid subgroup contributes to the overall phenolic content (Marinova et al., 
2005).  It was hypothesised that this result would be comparable with the concentrations 
of antioxidants as measured by HPLC. Unexpectedly, these two results were not 
analogous as goji berry showed the largest F: P with strawberry displaying the lowest. 
One factor which may have influenced these results is that the HPLC method was 
optimised for strawberry as previously stated, therefore the full potential of the other 
fruits was not exhibited. However, this may not be a true representation of the full 
potential of the fruit extracts, as previous studies have found cyanidin-3-glucoside to be 
the main antioxidant contributor for these berries (Del Pozo-Insfran et al., 2006; Aaby et 
al., 2007; Brito et al., 2014). Further optimisation of the TFC assay could investigate the 
use of a cyanidin compound as the measurement standard.  
 
 
4.4 Antioxidant Capacity (AC) 
 
The DPPH assay is an end point assay which measures the AC through the ability of 
neutralisation of DPPH molecules by TROLOX, resulting in discolouration which can 
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expressed as total antioxidant capacity (TAC) and percentage scavenging. Percentage 
scavenging is defined as the percentage at which the DPPH free radicals accept 
hydrogen atoms available from the hydrogen donor; this was obtained from the fruit or 
antioxidant tested with a given TROLOX equivalent. 
 
DPPH· radical scavenging assay is known as a gold standard assay for measuring the 
AC. This method is defined as the standardised method to use when calculating the AC 
and is known to be of superior quality in comparison to other available methods of AC 
calculation. The values yielded from this are utilised as reference points for the AC 
value in other fruits (Naik et al., 2015).  
 
Upon comparison of the fruits to their F: P ratio goji berry would have been expected to 
contain the highest AC, followed by cranberry>maqui berry>acai berry>strawberry. 
However, goji berry displayed the lowest antioxidant capacity and was surpassed by 
maqui an acai berry. In conjunction with this, the percentage scavenging was displayed 
to be above 100% for punicalagin, cranberry and cyanidin-3-glucoside vs TROLOX. 
This display of the percentage scavenging being above 100% is due to it being 
expressed as a TROLOX equivalence which may introduce the possibility to compare 
these fruits to a different antioxidant with a higher scavenging ability.  A lack of 
knowledge on how the fruits were freeze dried makes it difficult to establish the 
reasoning behind this. A study by Asami et al., (2003) compared freeze-dried 
strawberry to other available forms, showing the freeze-dried form to display the 
highest AC values. It could be possible that this process contributed to enhance the 
antioxidant availability, particularly within the cranberry sample. 
 
78 
 
 Freeze drying is the method by which water is removed via the sublimation of ice 
crystals. There have been many known advantages to this form of food preservation 
along with obvious explanations such as efficient food storage of heat sensitive 
biological material, the retention of morphological, biochemical and immunological 
properties as well as high viability or activity levels. The process of freeze drying can 
instigate these attributes from the food sample which may be an explanation of the high 
cranberry result. In addition to this, pre-treatment of the fruit may have occurred for the 
company to save in production costs (Ciurzyńska and Lenart., 2011).  
 
Other factors contributing to this result may include the combination of antioxidants 
present within the sample. Although the results display four antioxidants it may be 
possible that the AC is contributed to by these in combination with other antioxidants 
not detected at this time. Although this study was able to determine four antioxidants to 
be present within the fruit samples, in comparison to other studies it is conceivable to 
suggest that these compounds are not the only antioxidants present within the fruit 
extracts. For example, goji berries were found to contain a variety of antioxidants 
particularly vitamin C with maqui berry found to contain anthocyandins and 
proanthocyanidins contributing to their AC (Ionică et al., 2012; Fredes et al., 2012). 
Sources have found acai berry to contain a multitude of antioxidants consisting of 
anthocyanidins and proanthocyanidins as well as catechin, and phenolic acids (Schauss 
et al., 2006; Pacheco-Palencia et al., 2008).  
 
Although the DPPH assay is of gold standard, this is not bound by its comparisons to 
TROLOX. It may be possible to utilise another antioxidant that could prove to be a 
better comparison of antioxidant activity within the fruit samples e.g. ascorbic acid 
(Floegel et al., 2016). The comparison between TROLOX and the samples may have 
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been a limitation for expressing the percentage scavenging as there were clear 
indications of punicalagin having a higher scavenging capability. 
  
Also, despite the reputation of this assay, there are other assays available that express 
the AC of samples. The oxygen radical absorbing capacity (ORAC) assay expresses AC 
by the use of a free radical generator mixed with a fluorescein probe. Upon heating of 
the generator, the fluorescein is damaged resulting in a loss of fluorescence. When 
antioxidants interact with the free radicals, the loss in fluorescence is delayed and this is 
used to calculate the AC (Floegel et al., 2016; FLUOstar OPTIMA; Bmglabtech.com; 
2014).  The ferric reducing antioxidant power (FRAP) assay follows a single electron 
transfer mechanism where the antioxidants are oxidised by oxidants such as Fe (III). 
This is measured by obtaining an absorbance value to quantify the reducing capabilities 
of the antioxidant (Ou et al., 2002).  
 
The antioxidant content of the fruits is not the only factor to consider when exploring 
antioxidant capacity. It is also conceivable that although there is a low amount of a 
particular antioxidant present within the fruit, the antioxidant itself, regardless of 
amount may have the ability to exceed the capabilities of the other antioxidants which 
are more highly present. 
 
Another factor to consider when exploring the results obtained from this experiment 
consist of the DPPH assay being and in vitro assay in which there is no consideration of 
the living organism (the consumer) and the effect this fruit would have in an in vivo 
environment. This concerns the bioavailability of the fruit within the consumer. The 
question is raised as to how this fruit affects the body. This is due to the assumption of 
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the entire fruit being utilised within the assay whereas, due to bioavailability it may be 
possible that the fruit portions contributing the antioxidant activity may not impact the 
consumer. Miller et al., (2013) showed that absorption of vitamin E, C, carotenoids and 
catechins are well established and that diets high in fruits and vegetables increased 
blood serum antioxidant activity by 10%. An avenue to explore could be of 
bioavailability as conducted by Lila et al., (2013) in which the anthocyandins from 
maqui berry were tested within a model of the human gastrointestinal tract which 
showed that less than 10% of anthocyandin is bioaccessible. This is imperative to the 
exploration of the administration of antioxidants as a potential chemotherapeutic agent 
due to it the antioxidants being primarily present within the fibrous aspects of the fruits 
which are generally not consumed or are excreted without being digested.  
 
4.5 Growth Curves and Cell Viability 
 
The correct use of cell lines is an imperative factor when conducting assays of this kind. 
As expected from the SVG-p12 and U87-MG cell lines, it was apparent that the 
cancerous cell line had a higher rate of proliferation. This would be expected due to the 
hallmark of cancer which causes a disruption of the negative feedback mechanisms in 
place to decrease proliferative signalling. Defects within this feedback mechanism are 
what are capable of enhancing this proliferative effect (Hanahan and Weinberg., 2011).  
 
The U87-MG cell line doubled in cell number over 48 hours and continued to grow 
exponentially over a period of seven days. In comparison, the SVG-p12 cell line 
doubled over 72 hours and continued to grow exponentially over a seven day period. 
Both cell lines expressed an initial lag phase in growth which is to be expected in order 
for the cells to become acclimatised to their new environment post- seeding. The 
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PrestoBlue® used the reducing cell environment as an indicator of viability. However, 
upon conduction of the assay it became evident that a large impacting factor is cell 
number when measuring the response of cell. The linearity assay established that 
fluorescence was proportional to cell density over 24 hours. In combination with the 
doubling time of the cells, the results recognised that the appropriate time for 
subsequent testing would be after a 24 hour incubation period with an initial seeding 
density of 1000 cells per well.  
 
4.6 Dose Response 
 
To be able to explore the result of antioxidants within a diseased state, the antioxidant 
compounds showing the highest AC were carried into dose dependant experimentation 
in U87-MG and SVG-p12 cell lines. This was compared to the chemotherapeutic agent 
cisplatin. Cisplatin demonstrated cytotoxic effects by reducing the cell viability of both 
U87-MG and SVG-p12 cell lines in a concentration dependant manner. In comparison 
to this, punicalagin and cyanidin-3- glucoside demonstrated a decrease in viability over 
the time period in both cell lines but at a higher concentration.  
 
Cisplatin is a common chemotherapeutic treatment due to its ability to induce 
cytotoxicity through a variety of mechanisms. This could consist of the characteristics 
of the platinum anticancer drug by inhibiting molecular pathways necessary for cellular 
division. Also, platinum compounds have the ability to damage tumours by apoptosis in 
cancer cells where signalling networks that regulate proliferation and survival are 
altered. This may occur by the activation of various signal transduction pathways due to 
interactions with ROS, DNA, tumour necrosis factor (TNF), mitochondria, p53, calcium 
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signalling and caspases. This may be due to the inhibition of DNA synthesis and repair 
resulting in cell cycle arrest at the G1, S or G2-M phase – thus inducing apoptosis 
(Florea and Büsselburg., 2011).  
 
However, cisplatin is known for its side effects in normal tissue and so novel 
compounds to work alone or in combination with this are constantly being sought. The 
aim of identifying antioxidants as a potential chemotherapeutic agent is due to their 
interaction with ROS.  ROS have the ability to contribute to cancer initiation, 
progression and metastasis. Cancerous cells have increased ROS as compared to non-
cancerous cells which may contribute to oncogenic activation. Although this 
relationship remains unclear, oxidative DNA damage has been known to play a role 
within carcinogenesis and malignant transformation. ROS could mediate signalling 
cascades relating to survival, proliferation and resistance to apoptosis.  This could occur 
within cancer cells due to the ischemic environment and increased rates of metabolism 
(Wang and Yi., 2016).  
 
Clerkin et al., 2008, explained how anti-oxidative therapy could aid in the retardation of 
angiogenesis, rendering them to be a promising antiangiogenic strategy in cancer 
therapy. This may suggest antioxidants to be a suitable anti-cancer therapy due to their 
nutraceutical properties which could result in reduced side effects upon administration. 
Another avenue that could be explored may consist of a combination of therapies as 
suggested previously.  
 
As well as adding the antioxidant compounds to the cells, the fruit samples were also 
directly added to the cells. The results seem to address previous statements of how the 
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antioxidant capacity does not reflect the ability of the compound. In this instance, it is 
possible to suggest that strawberry and maqui berry have an effect upon the cell 
viability of U87-MG cells due to their ability to reduce the viability of the cells by 50%. 
To determine the effectivity of the assay, it could be possible to compare the method 
with the MTT assay ((3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) 
which has been used in studies where antioxidants have been the focus (Ghalli et al., 
2013). The commonality of the assay suggests extraction of the antioxidant from the 
fruit sample to be applied to the suitable cell line. Fruits used in this study were highly 
pigmented in their nature, this suggested that this interfered with the PrestoBlue® assay 
viability assay and so would not detect the true level of viability on the cells. 
 
4.7 Future Work 
 
In order to achieve a logical progression it would be advantageous to determine the full 
antioxidant profile of each fruit. From this it would be beneficial to identify the 
antioxidant activity of the compounds present, which could indicate the relevant 
antioxidants contributing to the AC of the fruit extract. To ensure this is accomplished it 
could be beneficial to prepare the fruit sample rather than purchasing from a company. 
This would ensure the ability of the processing to be factored in to the results obtained. 
Previous studies form this lab attempted to process the fruit extracts from the fresh form 
and at the time of expermentation however, this did not have a desirable outcome. Fresh 
fruits were processed with the aim of use within experimentation, yet the fruits were 
difficult to solubilise and utilise whilst maintaining them in their purest form. This was 
overcome within the study by diluting the fruits to suit the relevant experimentation 
(Patel, Raani and Salim; unpublished data). 
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As previously stated, the standard used in the antioxidant assays can contribute to the 
results obtained. Upon determination of the optimal standard to use to compare the 
results against, it may be ideal to explore the effect of the combination of antioxidants 
within the sample. This could enable further understanding into how the antioxidants 
interact with each other and to identify combinations that would have a higher AC thus, 
a better effect within the cell lines.  Previous research has extracted the antioxidants 
from the fruit samples prior to addition to cell culture. This would be ideal to determine 
the amount of antioxidants found in a serving size or choosing to explore a particular 
section of the fruit, for instance the skin, flesh, pith, seeds or the entire fruit which could 
solve the complication of the interference pigmentation. Having determined an AC of 
the fruit and the effect on cells, it would be beneficial to measure the bioavailability of 
the fruit. Experimentation for this could consist of the use of a model of the human 
gastrointestinal tract to quantify the bioavailability of the compound (Lila et al., 2013).  
 
The antioxidants explored within this study suggest an effect upon cell viability 
however, this does not determine cell death. Cell death could be explored with regards 
to these antioxidants through apoptosis assays. Leading on from this it could be 
beneficial to identify the interaction of the antioxidant within the cell cycle by 
considering cell cycle analysis and proliferation assays. Another avenue to explore 
could be the potential to use the antioxidant as a targeted drug therapy. In this case, 
exploration into the blood brain barrier could be beneficial.  
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4.8 Conclusions 
 
Results from this study have demonstrated that berries do contain antioxidants. Due to 
their pigmentation the flavonoid subgroup of anthocyanidins is favoured in this fruit 
type. However, this may not be the sole contributor to the antioxidant capacity. This 
study provides information about the interaction between antioxidants and glioblastoma 
multiforme cell line U87-MG. This opens the potential to explore antioxidants as a 
chemotherapeutic agent alone, or in combination with a platinum based 
chemotherapeutic agent.  
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Appendix 1: Limit of Detection 
Appendix 1.1: Limit of Detection of Punicalagin using HPLC method 1. 
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Appendix 1.2: Limit of Detection of Gallic acid using HPLC method 1 
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Appendix 1.3: Limit of Detection of cyanidin-3-glucoside using HPLC method 1. 
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Appendix 1.2: Limit of Detection of Malvidin using HPLC method 1. 
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Appendix 2: Spiking of Fruit Extracts 
Appendix 2.1: Strawberry extract spiked with punicalagin, gallic acid, cyanidin-3-
glucoside and malvidin. 
114 
 
Appendix 2.2: Goji berry extract spiked with Punicalagin, gallic acid, cyanidin-3-
glucoside and malvidin. 
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Appendix 2.3: Maqui berry extract spiked with Punicalagin, gallic acid, cyanidin-3-
glucoside and malvidin. 
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Appendix 2.3: Acai berry extract spiked with Punicalagin, gallic acid, cyanidin-3-glucoside 
and malvidin   
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Appendix 3: Standard Curves & Graphs 
Appendix 3.1: Standard curve constructed from the Total Flavonoid Content. Standard 
curve used to quantify the TFC for samples expressed as µg of catechin equivalents 
(CE)/ml. A positive correlation was observed between absorbance and catechin 
concentration at r2=0.97. 
 
Appendix 3.2: Standard curve constructed from the Total Phenolic Content. Standard 
curve used to quantify the TPC for samples expressed as µg of gallic acid equivalents 
(GAE)/ml. A positive correlation was observed between absorbance and gallic acid 
concentration at r2 = 0.99. 
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Appendix 3.3: Graphs from the DPPH assay 
 
Appendix 3.3.1: Standard curve constructed from the DPPH assay. Standard curve used 
to quantify the antioxidant capacity for samples expressed as µM of TROLOX 
equivalents (TE). A negative correlation was seen between absorbance and 
concentration of TROLOX at r2=0.99. 
Appendix 3.3.2: Percentage scavenging graph for the DPPH assay. Percentage 
scavenging curve, used to quantify the percentage at which the AAPH molecules were 
quenched by the antioxidant, for samples expressed as µM of TROLOX equivalents 
(TE). A positive correlation was found between percentage scavenging and TROLOX 
concentration at r2 = 0.85.  
